CJ Bioscience, Inc. (KOSDAQ:311690)

CJ Bioscience Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 26, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	107,267	121,770	131,831	147,076	170,481	286,048
Market Cap Growth	-23.49%	-7.63%	-10.37%	-13.73%	-40.40%	43.54%
Enterprise Value	66,840	74,179	98,118	116,989	139,502	291,080
Last Close Price	8210.00	9320.00	10090.00	16140.00	24887.51	41793.85
PS Ratio	29.05	32.98	38.03	26.38	41.84	65.56
PB Ratio	2.00	2.27	1.70	2.06	3.43	3.26
P/TBV Ratio	2.56	2.91	2.02	2.49	3.51	3.26
EV/Sales Ratio	18.10	20.09	28.30	20.98	34.24	66.72
Debt / Equity Ratio	0.19	0.19	0.12	0.12	0.58	0.27
Net Debt / Equity Ratio	-0.75	-0.75	-0.85	-0.78	-0.41	-0.64
Net Debt / EBITDA Ratio	1.95	1.95	2.20	2.07	0.69	6.58
Net Debt / FCF Ratio	1.73	1.73	2.34	1.86	0.81	5.98
Asset Turnover	0.04	0.04	0.04	0.06	0.04	0.05
Inventory Turnover	19.50	19.50	22.21	32.50	24.90	10.67
Quick Ratio	3.55	3.55	4.10	4.38	1.43	3.39
Current Ratio	3.61	3.61	4.14	4.43	1.46	3.42
Return on Equity (ROE)	-36.54%	-36.54%	-44.00%	-37.82%	-50.78%	-31.51%
Return on Assets (ROA)	-18.02%	-18.02%	-22.44%	-21.95%	-20.00%	-6.66%
Return on Capital Employed (ROCE)	-42.90%	-42.90%	-42.20%	-42.00%	-58.90%	-10.90%
Earnings Yield	-22.38%	-19.71%	-24.91%	-15.58%	-20.48%	-6.74%
FCF Yield	-21.84%	-19.24%	-21.34%	-20.28%	-14.73%	-3.28%
Buyback Yield / Dilution	-40.91%	-40.91%	-30.92%	-20.52%	-38.23%	-10.14%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.